Literature DB >> 28640680

Polysubstance Use Among US Women of Reproductive Age Who Use Opioids for Nonmedical Reasons.

Marian Jarlenski1, Colleen L Barry1, Sarah Gollust1, Amy J Graves1, Alene Kennedy-Hendricks1, Katy Kozhimannil1.   

Abstract

OBJECTIVES: To determine the prevalence and patterns of polysubstance use among US reproductive-aged women who use opioids for nonmedical purposes.
METHODS: We used the National Survey of Drug Use and Health (2005-2014) data on female respondents aged 18 to 44 years reporting nonmedical opioid use in the past 30 days (unweighted n = 4498). We categorized patterns of polysubstance use in the past 30 days, including cigarettes, binge drinking, and other legal and illicit substances and reported prevalence adjusted for age, race/ethnicity, and educational attainment.
RESULTS: Of all women with nonmedical opioid use, 11% reported only opioid use. Polysubstance use was highest in non-Hispanic White women and women with lower educational attainment. The most frequently used other substances among women using opioids nonmedically were cigarettes (56.2% smoked > 5 cigarettes per day), binge drinking (49.7%), and marijuana (32.4%). Polysubstance use was similarly prevalent among pregnant women with nonmedical opioid use.
CONCLUSIONS: Polysubstance use is highly prevalent among US reproductive-aged women reporting nonmedical opioid use. Public Health Implications. Interventions are needed that address concurrent use of multiple substances.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28640680      PMCID: PMC5508143          DOI: 10.2105/AJPH.2017.303825

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  8 in total

1.  The Affordable Care Act Transformation of Substance Use Disorder Treatment.

Authors:  Amanda J Abraham; Christina M Andrews; Colleen M Grogan; Thomas D'Aunno; Keith N Humphreys; Harold A Pollack; Peter D Friedmann
Journal:  Am J Public Health       Date:  2017-01       Impact factor: 9.308

Review 2.  Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review.

Authors:  Nicholas B King; Veronique Fraser; Constantina Boikos; Robin Richardson; Sam Harper
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

3.  Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data.

Authors:  Meredith S Shiels; Pavel Chernyavskiy; William F Anderson; Ana F Best; Emily A Haozous; Patricia Hartge; Philip S Rosenberg; David Thomas; Neal D Freedman; Amy Berrington de Gonzalez
Journal:  Lancet       Date:  2017-01-26       Impact factor: 79.321

4.  Women-Centered Drug Treatment Services and Need in the United States, 2002-2009.

Authors:  Mishka Terplan; Nyaradzo Longinaker; Lindsay Appel
Journal:  Am J Public Health       Date:  2015-09-17       Impact factor: 9.308

5.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009.

Authors:  Stephen W Patrick; Robert E Schumacher; Brian D Benneyworth; Elizabeth E Krans; Jennifer M McAllister; Matthew M Davis
Journal:  JAMA       Date:  2012-04-30       Impact factor: 56.272

Review 6.  Overview and epidemiology of substance abuse in pregnancy.

Authors:  Andria D Wendell
Journal:  Clin Obstet Gynecol       Date:  2013-03       Impact factor: 2.190

Review 7.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14

8.  Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-07-05       Impact factor: 17.586

  8 in total
  21 in total

1.  Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use.

Authors:  Verena E Metz; Qiana L Brown; Silvia S Martins; Joseph J Palamar
Journal:  Drug Alcohol Depend       Date:  2017-12-27       Impact factor: 4.492

2.  Cigarette Smoking Status and Substance Use in Pregnancy.

Authors:  Emmanuel A Oga; Katrina Mark; Victoria H Coleman-Cowger
Journal:  Matern Child Health J       Date:  2018-10

3.  Binge Drinking and Prescription Opioid Misuse in the U.S., 2012-2014.

Authors:  Marissa B Esser; Gery P Guy; Kun Zhang; Robert D Brewer
Journal:  Am J Prev Med       Date:  2019-06-11       Impact factor: 5.043

4.  Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis.

Authors:  Theodore J Cicero; Matthew S Ellis; Zachary A Kasper
Journal:  Am J Public Health       Date:  2019-12-19       Impact factor: 9.308

5.  Trends in heroin use among women of reproductive age in the United States, 2004-2017.

Authors:  Alyssa Vanderziel; Maria A Parker; Omayma Alshaarawy
Journal:  Addict Behav       Date:  2020-06-22       Impact factor: 3.913

6.  Increased Severity of Neonatal Abstinence Syndrome Associated With Concomitant Antenatal Opioid and Benzodiazepine Exposure.

Authors:  Lauren A Sanlorenzo; William O Cooper; Judith A Dudley; Shannon Stratton; Faouzi I Maalouf; Stephen W Patrick
Journal:  Hosp Pediatr       Date:  2019-07-01

Review 7.  Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women.

Authors:  Marcela C Smid; Torri D Metz; Adam J Gordon
Journal:  Clin Obstet Gynecol       Date:  2019-03       Impact factor: 2.190

8.  Five-Year Outcomes Among Medicaid-Enrolled Children With In Utero Opioid Exposure.

Authors:  Marian P Jarlenski; Elizabeth E Krans; Joo Yeon Kim; Julie M Donohue; A Everette James; David Kelley; Bradley D Stein; Debra L Bogen
Journal:  Health Aff (Millwood)       Date:  2020-02       Impact factor: 6.301

9.  Patterns, contexts, and motivations for polysubstance use among people who inject drugs in non-urban settings in the U.S. Northeast.

Authors:  Pablo K Valente; Angela R Bazzi; Ellen Childs; Peter Salhaney; Joel Earlywine; Jennifer Olson; Dea L Biancarelli; Brandon D L Marshall; Katie B Biello
Journal:  Int J Drug Policy       Date:  2020-09-07

10.  Factors Associated with Child-Welfare Involvement among Prenatally Substance-Exposed Infants.

Authors:  Stephanie Anne Deutsch; Jennifer Donahue; Trenee Parker; Jobayer Hossain; Allan De Jong
Journal:  J Pediatr       Date:  2020-05-14       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.